Cyberport incubatee M Visioner plans to launch its signature product “3D Intelligent Pathological Medical Image Solutions” to the market this October. The company has drawn on medical imaging, computer science, physics and virtual reality technology to develop the first virtual reality medical platform in Mainland China, and the team has strong experience in MRI medical solution and has collaborated with research institutes in Asia to commercialise medical products.
Highlights of the new product include the solution’s ability to deliver computer-assisted diagnosis, preoperative planning and medical education. It can also facilitate medical skills training and enhance doctor patient communication.
M Visioner is currently collaborating with the Guangzhou Zhongshan No 2 Hospital, one of the earliest western hospitals with leading influence in the medical industry in China, to establish the Mainland’s first medical virtual reality laboratory.
The solution, now in the process of obtaining CFDA Type II accreditation, has been fine-tuned by medical practitioners to ensure scanned 2D images can be properly converted into 3D computer readable data and signals in order to streamline analysis, diagnosis and operations.
“With Cyberport’s support, our project is gaining greater recognition from professional investors. We have been able to meet many young entrepreneurs and share their ideas, problems and solutions. We were also able to tap into the expertise of Cyberport during our process of development. This really helped us,” said Mr. Ronald Tse, CEO of M Visioner.
M Visioner received Cyberport Creative Micro Fund (CCMF) grant in Jun 2015 and newly admitted into Cyberport Incubation Programme this year. The company also acquired investment funding in Oct 2015 for product development, and is expanding their business to Beijing, Shanghai, Chengdu and Shenzhen regions.
Visit www.mvisioner.com for more information.
